Abstract:Graphical and Lay Summary The application of the Design‐Build‐Test‐Learn (DBTL) framework in enhancing erythromycin production from Saccharopolyspora erythraea. Through systematic metabolic engineering, a genetically modified strain was developed, showing improved erythromycin synthesis by suppressing the sucC gene and enhancing NADPH availability. Transcriptomic and metabolomic analyses revealed significant metabolic alterations, particularly in central carbon, amino acid, energy, and co‐factor/vitamin metabolism pathways. Despite increased amino acid metabolism leading to nitrogen depletion and potential cellular autolysis during fermentation, refining the process through ammonium sulfate supplementation resulted in a remarkable 43.5% increase in erythromycin yield (1125.66 mg/L). This work highlights the efficacy of the DBTL methodology in optimizing antibiotic production and offers insights into addressing the global challenge of antibiotic resistance. Industrial production of bioactive compounds from actinobacteria, such as erythromycin and its derivatives, faces challenges in achieving optimal yields. To this end, the Design‐Build‐Test‐Learn (DBTL) framework, a systematic metabolic engineering approach, was employed to enhance erythromycin production in Saccharopolyspora erythraea (S. erythraea) E3 strain. A genetically modified strain, S. erythraea E3‐CymRP21‐dcas9‐sucC (S. erythraea CS), was developed by suppressing the sucC gene using an inducible promoter and dcas9 protein. The strain exhibited improved erythromycin synthesis, attributed to enhanced precursor synthesis and increased NADPH availability. Transcriptomic and metabolomic analyses revealed altered central carbon metabolism, amino acid metabolism, energy metabolism, and co‐factor/vitamin metabolism in CS. Augmented amino acid metabolism led to nitrogen depletion, potentially causing cellular autolysis during later fermentation stages. By refining the fermentation process through ammonium sulfate supplementation, erythromycin yield reached 1125.66 mg L−1, a 43.5% increase. The results demonstrate the power of the DBTL methodology in optimizing erythromycin production, shedding light on its potential for revolutionizing antibiotic manufacturing in response to the global challenge of antibiotic resistance.

Improving heterologous polyketide production in Escherichia coli by transporter engineering

Heterologous erythromycin production across strain and plasmid construction

Metabolically engineered Escherichia coli for efficient production of glycosylated natural products

Mining and engineering exporters for titer improvement of macrolide biopesticides in Streptomyces

Metabolic Engineering Strategies Based on Secondary Messengers (p)ppgpp and C-di-GMP to Increase Erythromycin Yield in Saccharopolyspora Erythraea.

Dissecting and engineering of the TetR family regulator SACE_7301 for enhanced erythromycin production in Saccharopolyspora erythraea

Heterologous Production and Yield Improvement of Epothilones in Burkholderiales Strain DSM 7029

Comparative Genomic and Transcriptomic Analysis Guides to Further Enhance the Biosynthesis of Erythromycin by an Overproducer

Toward Improvement of Erythromycin A Production in an Industrial Saccharopolyspora Erythraea Strain Via Facilitation of Genetic Manipulation with an Artificial Attb Site for Specific Recombination.

Enhancing erythromycin production in Saccharopolyspora erythraea through rational engineering and fermentation refinement: A Design‐Build‐Test‐Learn approach

Harnessing the intracellular triacylglycerols for titer improvement of polyketides in Streptomyces

Genetic Modulation of the Overexpression of Tailoring Genes Eryk and Eryg Leading to the Improvement of Erythromycin A Purity and Production in Saccharopolyspora Erythraea Fermentation

Fermentation Optimization and Industrialization of Recombinant Saccharopolyspora Erythraea Strains for Improved Erythromycin A Production

Engineering the Erythromycin-Producing Strain Saccharopolyspora erythraea HOE107 for the Heterologous Production of Polyketide Antibiotics

Engineering yeast subcellular compartments for increased production of the lipophilic natural products ginsenosides

Co‐augmentation of a transport gene mfsT1 in Mycolicibacterium neoaurum with genome engineering to enhance ergothioneine production

Inactivation of SACE_3446, a TetR Family Transcriptional Regulator, Stimulates Erythromycin Production in Saccharopolyspora Erythraea

Optimizing heterologous protein production in the periplasm of E. coli by regulating gene expression levels

Knocking out of Tailoring Genes Eryk and Eryg in an Industrial Erythromycin-Producing Strain of Saccharopolyspora Erythraea Leading to Overproduction of Erythromycin B, C and D at Different Conversion Ratios

Metabolic engineering for improving ectoine production in Escherichia coli

Developing a dynamic equilibrium system in Escherichia coli to improve the production of recombinant proteins